Dysregulation of the PI3K/Akt/mTOR pathway has been found to be involved in tumorigenesis and disease progression in NSCLC, including angiogenesis, migration, metastasis, proliferation, and apoptosis [15,16]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.